DSM Invests in Probiotics Startup

DSM says that its DSM Ventures subsidiary and private equity firm Capital Resource Partners (CRP; Boston) have each invested in Ganeden Biotech (Mayfield Heights, OH), a manufacturer of dietary supplements focused on digestive health. DSM and CRP have invested a combined $12 million. Further financial details were not disclosed. Ganeden’s products are based on the use of a spore-forming and lactic acid-producing bacterium, Bacillus...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers